NIH-funded research R15 grant

Using cell transformation to improve heart disease treatment

Official title: Harnessing endothelial cell transdifferentiation for cardiovascular therapy

Funded at Boise State University · NIH-10513527 · Data updated 2026-11-12

This study is looking at how certain cells in your blood vessels can turn into different types of cells to help treat heart problems, and it aims to find out if this change helps deliver important genetic material to heart cells, which could lead to new ways to improve heart health and repair damage.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionBoise State University
NIH-funded
Lab location1 site (Boise, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2025
Funding year2022
Award (this year)$408,731
NIH project number1R15HL165397-01
Project IDNIH-10513527 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from cardiovascular diseases who may benefit from new treatment approaches.

Less likely to help

Patients with non-cardiovascular conditions or those who do not have any heart-related issues may not benefit from this research.

What this research studies

This research investigates how endothelial cells can change into other cell types to help treat cardiovascular diseases. The team will explore whether this transformation is responsible for delivering genetic material to heart cells through a viral vector. By using advanced techniques, they aim to understand the mechanisms behind this process and identify specific areas in the body where these changes occur. This could lead to new strategies for enhancing heart health and repairing damaged tissues.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that improve heart function and recovery from cardiovascular diseases.

How similar studies have gone: While the approach of using cell transdifferentiation is gaining interest, this specific application in cardiovascular therapy is relatively novel and has not been extensively tested.

Where this research is happening

  • Boise State University
    Boise, United States
    Active

Researchers

  • Principal investigator: Morrison, Brad — Boise State University
  • Study coordinator: Morrison, Brad

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.